GM
Gautam Madhok
About Gautam Madhok
Data last updated:
Gautam Madhok has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Higgs Healthcare Limited and Higgs Life Sciences Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Higgs Life Sciences Private Limited at ₹1.89 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Dec 2019 | 2019 | ₹1.89 Cr (FY 2025) | Active | |
| Director | 15 Oct 2018 | 2018 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gautam Madhok
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gautam Madhok
Gautam Madhok has 8 years in corporate governance. Holds Director role. Currently with 2 companies, including Higgs Healthcare Limited and Higgs Life Sciences Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations. The largest current company by reported revenue is Higgs Life Sciences Private Limited at ₹1.89 Cr (FY 2025).
Gautam Madhok is associated with 2 companies as Director, including Higgs Life Sciences Private Limited (₹1.89 Cr), Higgs Healthcare Limited.
Gautam Madhok has expertise in Healthcare, General Business.
Gautam Madhok has 8 years in corporate governance.
By reported revenue, the largest current company of Gautam Madhok is Higgs Life Sciences Private Limited, with revenue of ₹1.89 Cr (FY 2025).
Gautam Madhok currently holds positions at 2 companies: Higgs Life Sciences Private Limited (₹1.89 Cr), Higgs Healthcare Limited.